AKT1 and lung carcinoma: Our study found that IFN-γ- and sPD-1-overexpressing BMSCs significantly reduced the relative positive expression of PI3K and AKT in lung cancer tissues, blocking the signaling pathway and inhibiting tumor cell growth and metastasis.